After spending the past year extending its portfolio of continuous glucose monitors to include people who may not have ...

Abbott and Dexcom settled all patent lawsuits related to continuous glucose monitors (CGMs ... In March 2024, a jury found that Dexcom’s G6 glucose monitors infringed one of three of Abbott’s patents, ...

Acton, Massachusetts-based Insulet touts Omnipod 5 as the number one insulin pump for new users in Europe. It remains the top ...

North Chicago-based Abbott announced last month it reached a settlement agreement with Dexcom over all outstanding patent disputes relating to their glucose monitoring products, which estimate blood ...

Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its ...

In a report released yesterday, William Plovanic from Canaccord Genuity maintained a Buy rating on Dexcom (DXCM – Research Report), with a ...

Dexcom is a developer and marketer of continuous glucose monitoring ... Its top products include the Dexcom G6 which provides real-time glucose monitoring, Dexcom G7 which is user-friendly ...

This week, Dexcom became the first medical device company to integrate generative AI into a continuous glucose monitor. The company added generative AI to its Stelo glucose monitor, which it began ...

Abbott’s Lingo offers real-time glucose tracking to improve health and wellness. See my hands-on experience and if it’s worth ...

DexCom, Inc. (DXCM), a maker of continuous glucose monitoring systems for diabetes management, on Monday reported a rise in ...

Dec 23 (Reuters) - Abbott Laboratories (ABT.N), opens new tab and DexCom (DXCM.O), opens ... patent disputes between them related to continuous glucose monitoring devices. The agreement will ...